The American Diabetes Association Standards of Care in Diabetes are a “living” guideline – the recommendations are updated throughout the year and major revisions occur in January. In this episode, guest host, Jake Galdo, is joined by Susan Cornell as they evaluate new pharmacotherapy recommendations in the ADA Standards of Care.
Treatment recommendations for diabetes are no longer metformin plus. Now initial, and augmented therapy, is driven by comorbid conditions.
00:00 - Introductions
02:09 - Reason for ADA Standards of Care Update
05:09 - The GameChanger: Comorbid Condition-Driven Therapy
08:32 - Connecting to Practice: Clinical Decision Points
11:13 - Diabetes Therapies Use for Weight Loss and Drawbacks
13:29 - Lifestyle Modification Suggestions
19:48 - Insulin Use According to New Guidelines
25:03 - Pharmacy Intervention Opportunity: Glucagon
26:37 - Closing Remarks
John A Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, Education Projects, CEimpact
Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES
Associate Director, Experiential Education
Professor, Pharmacy Practice
Midwestern University College of Pharmacy
References and Resources
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the first line therapy for treatment of diabetes
2. Discuss key clinical decision points for the treatment of diabetes
0.05 CEU/0.5 Hr
Initial release date: 01/09/2023
Expiration date: 01/09/2024
Additional CPE and CME details can be found here.
Follow CEimpact on Social Media:
Download the CEimpact App for Free Continuing Education + so much more!